Fig. 3: DC-based cancer therapy strategies. | Cell Death & Disease

Fig. 3: DC-based cancer therapy strategies.

From: The emerging role of dendritic cells in the tumor microenvironment: from antigen presentation to targeted immunotherapy

Fig. 3

Current dendritic cell (DC)-based cancer immunotherapeutic strategies include DC vaccines, either alone or in combination with immune checkpoint blockade (ICB), adoptive cell transfer (ACT), and conventional therapies. In parallel, platforms and adjuvants targeting endogenous DCs have shown significant potential in enhancing antitumor immunity. Furthermore, strategies aimed at reversing the immunosuppressive tumor microenvironment can improve the efficacy of DC-based immunotherapies. PLG: poly-lactide-co-glycolide. Created with BioRender.com.

Back to article page